SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-002293
Filing Date
2022-02-28
Accepted
2022-02-28 16:13:07
Documents
83
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fate-20211231.htm   iXBRL 10-K 4152885
2 EX-10.40 fate-ex10_40.htm EX-10.40 426929
3 EX-23.1 fate-ex23_1.htm EX-23.1 6015
4 EX-31.1 fate-ex31_1.htm EX-31.1 13675
5 EX-31.2 fate-ex31_2.htm EX-31.2 15140
6 EX-32.1 fate-ex32_1.htm EX-32.1 8756
7 EX-32.2 fate-ex32_2.htm EX-32.2 9002
8 GRAPHIC img141040381_0.jpg GRAPHIC 162585
9 GRAPHIC img141040381_1.jpg GRAPHIC 36489
  Complete submission text file 0000950170-22-002293.txt   15700082

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fate-20211231_cal.xml EX-101.CAL 60545
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fate-20211231_pre.xml EX-101.PRE 516021
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fate-20211231_def.xml EX-101.DEF 336435
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fate-20211231_lab.xml EX-101.LAB 695492
14 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fate-20211231.xsd EX-101.SCH 81196
77 EXTRACTED XBRL INSTANCE DOCUMENT fate-20211231_htm.xml XML 3087435
Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 651311552 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36076 | Film No.: 22689661
SIC: 2836 Biological Products, (No Diagnostic Substances)